'Capping Off' Ceremony 

We're on the Move! Starting from May 28th, 2024, you will find all the details of our Recombumin® portfolio and Albumedix' services at our new online home, sartorius.com
  • Contact
  • Albumin
    • Why albumin
    • Recombumin® products
    • Sample page
  • Solutions
    • Recombumin® Products
    • Compliance Services
    • Innovation Services
    • Veltis technology
  • Applications
    • Cell therapy
    • Gene therapy
    • Vaccine stabilization
    • Medical device coating
    • Protein & peptide formulation
    • COVID-19
  • About
    • About Albumedix
    • Partnering
      • R&D collaborations
      • Pipeline
    • Careers
    • CSR
    • FAQ
  • Media
    • Scientific Library
    • News & Events
    • Blog
Albumedix Media Blog Christmas 'Capping Off' Ceremony

Christmas 'Capping Off' Ceremony

08 Jan 2020

In December, Albumedix held a 'Capping off Ceremony' to celebrate the brand new, four-storey manufacturing plant extension being confirmed as watertight!

It was a fantastic morning, (for more reasons than just the complimentary breakfast butties & the opportunity to catch up with colleagues from every department!) where we heard motivational speeches from the CEO (Peter Rosholm) about the companies bright future plans & unveiled the dedication plaque. We even had the opportunity to explore the space on each of the new floors. With the project currently on-track and on-time, it was great to celebrate the hard work and support of Albumedix, Scitech (our construction partner) and the landlords all together. 

We followed this up with some traditional 'capping off' ceremony activities. Historically, topping a newly constructed building off with a tree formed part of a ritual designed to make peace with the gods. Some accounts track the first known instance to Egypt and the completion of the first pyramid, where the workers placed a tree on top to honour their fellow builders who had died during construction - the tree being a sign of everlasting life.

In Scandinavia, a more widespread practice was followed. When the timber frame of a building was complete, a tree was placed on the highest point to appease the tree-dwelling spirits whose habitat had been disturbed. Viking invaders took the custom to Britain where the tradition has also lived on since.

With a nod to our companies partially Danish history and the festive time of year, we opted for a Christmas tree and three flags to top our building off.

This ceremony was the perfect end to a very successful 2019 for Albumedix, stay with us for more expansion updates as we move into 2020!

CONTACT

Albumedix Ltd.
Mabel Street
The Meadows
Nottingham
NG2 3ED, United Kingdom
Tel: +44 115 9553379
info@albumedix.com

 

Albumedix - Dedicated to Better Health

Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with ~100 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.

 

Privacy | Cookies | Patent Portfolio

ALBUMEDIX, the ALBUMEDIX LOGO, DEDICATED TO BETTER HEALTH and marks such as RECOMBUMIN and VELTIS are trademarks of Albumedix. Albumedix© Copyright 2018

FOLLOW US

  • Albumin
    • Why albumin
    • Recombumin® products
    • Sample page
  • Solutions
    • Recombumin® Products
    • Compliance Services
    • Innovation Services
    • Veltis technology
  • Applications
    • Cell therapy
    • Gene therapy
    • Vaccine stabilization
    • Medical device coating
    • Protein & peptide formulation
    • COVID-19
  • About
    • About Albumedix
    • Partnering
      • R&D collaborations
      • Pipeline
    • Careers
    • CSR
    • FAQ
  • Media
    • Scientific Library
    • News & Events
    • Blog

We use cookies on our website to improve the website and your experience.

Read more